A PROSPECTIVE OPEN-LABEL TRIAL WITH LENALIDOMIDE IN POEMS SYNDROME

被引：0
|
作者：
Terenghi, F. [1 ]
Nozza, A. [2 ]
Gallia, F. [1 ]
Mazza, R. [2 ]
Briani, C. [3 ]
Adami, F. [4 ]
Lessi, F. [4 ]
Di Pietro, D. [1 ]
D'Ambrosio, C. M. [3 ]
Santoro, A. [2 ]
Nobile-Orazio, E. [1 ]
机构：
[1] Univ Milan, Humanitas Clin & Res Inst, Dept Med Biotechnol & Translat Med, Milan, Italy
[2] Humanitas Clin & Res Inst, Humanitas Canc Ctr, Oncol & Hematol Dept, Milan, Italy
[3] Univ Padua, Dept Neurosci, Padua, Italy
[4] Univ Padua, Dept Clin & Expt Med Hematol & Clin Immunol, Padua, Italy
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [1] A PROSPECTIVE OPEN-LABEL TRIAL WITH LENALIDOMIDE IN POEMS SYNDROME: PRELIMINARY RESULTS
    Terenghi, F.
    Nozza, A.
    Gallia, F.
    Mazza, R.
    Briani, C.
    Adami, F.
    Lessi, F.
    Gandolfi, S.
    Santoro, A.
    Nobile-Orazio, E.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2012, 17 : S54 - S54
  • [2] Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial
    Nozza, Andrea
    Terenghi, Fabrizia
    Gallia, Francesca
    Adami, Fausto
    Briani, Chiara
    Merlini, Giampaolo
    Giordano, Laura
    Santoro, Armando
    Nobile-Orazio, Eduardo
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (05) : 748 - 755
  • [3] EFFICACY AND SAFETY OF LENALIDOMIDE AND DEXAMETHASONE IN POEMS SYNDROME: RESULTS OF A PROSPECTIVE OPEN LABEL TRIAL
    Gallia, F.
    Nozza, A.
    Terenghi, F.
    Briani, C.
    Adami, F.
    Santoro, A.
    Nobile-Orazio, E.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 146 - 146
  • [4] A Prospective Open-Label Trial of Buspirone for the Treatment of Anxiety in Williams Syndrome
    Thom, Robyn P.
    Renzi, Danielle
    Pecukonis, Meredith
    Mullett, Jennifer
    Ravichandran, Caitlin
    Mcdougle, Christopher J.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2024,
  • [5] A Prospective Phase II Trial of Lenalidomide and Dexamethasone in POEMS Syndrome
    Jaccard, Arnaud
    Karlin, Lionel
    Hebraud, Benjamin
    Frenzel, Laurent
    Choquet, Sylvain
    Mohty, Mohamad
    Dib, Mamoun
    Vincent, Laure
    Slama, Borhane
    Galicier, Lionel
    Tournilhac, Olivier
    Belhadj-Merzoug, Karim
    Moreau, Philippe
    Decaux, Olivier
    Benboubker, Lofti
    Caillot, Denis
    Fontan, Jean
    Maisonneuve, Herve
    Bender, Sebastien
    Musset, Lucile
    Fermand, Jean-Paul
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E41 - E41
  • [6] A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome
    McCoy, Blathnaid
    Wang, Laura
    Zak, Maria
    Al-Mehmadi, Sameer
    Kabir, Nadia
    Alhadid, Kenda
    McDonald, Kyla
    Zhang, Grace
    Sharma, Rohit
    Whitney, Robyn
    Sinopoli, Katia
    Snead, O. Carter, III
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2018, 5 (09): : 1077 - 1088
  • [7] An open-label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome
    He, Haiyan
    Hou, Nan
    Chen, Xi
    Song, Yaqi
    Qiang, Wanting
    Liu, Jin
    Lu, Jing
    Fu, Weijun
    Du, Juan
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (02) : 478 - 482
  • [8] A prospective, open-label trial of olanzapine in adolescents with schizophrenia
    Findling, RL
    McNamara, NK
    Youngstrom, EA
    Branicky, LA
    Demeter, CA
    Schulz, SC
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (02): : 170 - 175
  • [9] A prospective, open-label trial of galantamine in autistic disorder
    Nicolson, Rob
    Craven-Thuss, Beth
    Smith, Judy
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (05) : 621 - 629
  • [10] Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial
    Fukushima, Yasushi
    Suzuki, Hidekazu
    Matsuzaki, Juntaro
    Kiyosue, Arihiro
    Hibi, Toshifumi
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 18 (03) : 317 - 323
12345